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Abstract: Licorice has been used in Chinese folk medicine for the treatment of various 
disorders.  Licorice  has  the  biological  capabilities  of  detoxication,  antioxidation,  and 
antiinfection.  In this  study,  we  evaluated the  antihepatotoxic  effect of  licorice  aqueous 
extract (LE) on the carbon tetrachloride (CCl4)-induced liver injury in a rat model. Hepatic 
damage,  as  reveled  by  histology  and  the  increased  activities  of  serum  aspartate 
aminotransferase  (AST),  alanine  aminotransferase  (ALT),  alkaline  phosphatase  (ALP) 
activities, and decreased levels of serum total protein (TP), albumin (Alb) and globulin (G) 
were induced in rats by an administration of CCl4 at 3 mL/kg b.w. (1:1 in groundnut oil). 
Licorice extract significantly inhibited the elevated AST, ALP and ALT activities and the 
decreased TP, Alb and G levels caused by CCl4 intoxication. It also enhanced liver super 
oxide  dismutase  (SOD),  catalase  (CAT),  glutathione  peroxidase  (GSH-Px),  glutathione 
reductase (GR), Glutathione S-transferase (GST) activities and glutathione (GSH) level, 
reduced  malondialdehyde  (MDA)  level.  Licorice  extract  still  markedly  reverses  the 
increased liver hydroxyproline and serum TNF-α levels induced by CCl4 intoxication. The 
data of  this  study  support  a  chemopreventive  potential  of  licorice  extract  against  liver 
oxidative injury. 
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1. Introduction 
Liver is the key organ of metabolism and excretion. It is often exposed to a variety xenobiotics and 
therapeutic agents. Until today, people have not yet found an actual curative therapeutic agent for liver 
disorder. In fact, most of the available remedies help the healing or regeneration of the liver. The 
hepatotoxin carbon tetrachloride (CCl4) is frequently used to induce liver fibrosis in animal models [1]. 
Treatment with  CCl4 generates  free radicals that trigger a cascade of  events that result  in  hepatic 
fibrosis,  mimicking  the  oxidative  stress  that  has  a  fibrogenic  effect  on  HSC  [2–4].  In  fact,  
reactive  oxygen  species  may  cause  tissue  injury  through  activation  of  the  precursors  of  MMPs 
(proMMPs) [2,4,5]. Although no successful therapeutic approach to this pathogenetic mechanism in 
liver  disease  has  been  developed,  antioxidants  therapies  have  shown  to  achieve  some  positive  
effects [6–8]. 
Natural  remedies  from  medicinal  plants  are  considered  to  be  effective  and  safe  alternative 
treatments  for hepatotoxicity.  In  view of this, the present study was undertaken to investigate the 
hepatoprotective activity of licorice extract against CCl4 induced hepatotoxicity in male Wistar rats. 
Licorice has been used as a medicinal plant for thousands of years. The active component of licorice, 
glycyrrhizic acid,  is hydrolyzed in vivo to glycyrrhetinic acid, which is responsible for most of its 
pharmacological properties. In ancient Chinese medicine and during Roman times, licorice was also 
recommended to cure sterility in women [9,10]. Licorice has held claim for therapeutic use for fevers, 
liver  ailments,  dyspepsia,  gastric  ulcers,  sore  throats,  asthma,  bronchitis,  Addison’s  disease  and 
rheumatoid arthritis and has been used as a laxative, antitussive and expectorant [11–13]. Among its 
most consistent uses are as a demulcent for the digestive system, to treat coughs, to soothe sore throats, 
and as a flavoring agent. 
The present study was undertaken to evaluate the protective effect of licorice aqueous extract on 
CCl4-induced  hepatotoxicity.  In  addition,  the  antioxidant  property  of  licorice  aqueous  extract  in  
liver-injured rats was investigated. 
2. Material and Method 
2.1. Chemicals 
Licorice  was  purchased  from  a  local  herb  shop  in  Shanghai  city,  China  in  March  2011  and 
identified by Dr. X.J. Hu in College of Pharmacy, Shanghai Jiaotong University. A voucher specimen 
(No. 20110314) was deposited in the laboratory of this faculty. The plant material was dried at ambiant 
temperature and stored in a dry place prior to use. 
Bifendate which is a recognised hepatoprotective drug in China was obtained from Zhejiang Wepon 
pharmacy Co. (Wenling, China). All other chemicals and reagents were of analytical grade. Int. J. Mol. Sci. 2011, 12                       
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2.2. Preparation of the Aqueous Extract of Licorice 
The licorice root was washed well with water, dried at room temperature in the dark, and then 
ground in an electric grinder to give a coarse powder. A batch of 200 g of the licorice powder was 
suspended in 3 L of distilled water, and the mixture was boiled under reflux for 30 min. The decoction 
obtained was centrifuged at 8000 g for 10 min, and the supernatant was collected. The supernatant was 
then filtered with Whatman No. 1 filter paper to remove cellulose fibers. The filtrate was concentrated 
on a steam bath to give 60 g of the residue. The resulting residue was then dried using a lyophilizer 
(Four-Ring Science Instrument Plant, Beijing, Co., Ltd.). The yield of the lyophilized dry product was 
approximately 23% (w/w). 
2.3. Animals 
Wistar rats (200–250 g) of either sex were maintained under standard environmental conditions and 
had free access to feed and water. Experiments on animals were performed based on animal ethics 
guidelines of Institutional Animal Ethics Committee. 
The rats were divided randomly into six groups of 10 rats. Four groups were administered with 100, 
150, 300 mg/kg, of the licorice extract orally or bifendate (100 mg/kg) daily (positive control). The 
licorice extract was suspended in distilled water and administered orally through an intragastric tube at 
the dose of 100, 150, 300 mg/kg b.w. One group (n = 10) with the same number of rats served as a 
normal control and one group (n = 10) and the same number of rats served as a model control.  
The selection of licorice extract dosage was based on our previous study wherein licorice extract 
administered at 300 mg/kg b.w./day for 15 days did not elicit any toxic symptoms in rats nor affected 
food intake or body weight gain. After 15 days, the rats (except for normal control) were given an 
acute oral dose of CCl4 at 3 mL/kg b.w. (1:1 in groundnut oil). The animals were housed individually 
in metallic cages at room temperature (25 ± 2 °C) with relative humidity of 50–60% and on a 12 h 
light–dark cycle. They had free access to food and water ad libitum. The food intake was monitored 
daily and the growth of animals was monitored weekly by recording body weight.  
According to some Chinese medical literature [14], the dosage of licorice raw herb typically used in 
a clinic was about 10–30, or even 40 g in single use or in formulation. Excellent effect and no toxicity 
were observed in clinical practice. The result and dosage in the present study fit the clinical study, that 
is, if we use conversion table to compute the clinical dosage from the animal dosage, 100–300 mg/kg, 
it will be 10–40 g, near clinical usage. Hence, the licorice extracts at a dose of 100, 150 or 300 mg/kg 
BW were orally administered to rats injected with or without CCl4 treatment before CCl4 exposure.  
The animals were sacrificed 8 h after CCl4 administration under light ether anesthesia. Blood was 
drawn by cardiac puncture for separation of serum. Liver organs were excised, blotted, weighed and 
processed for histopathology and biochemical assays. Ten or 20% (w/v) homogenates of the tissues 
were prepared in various buffers as per the requirement in specific assays. 
Liver index was measured according to the formula: (rat liver weight/rat body weight) × 100%. Int. J. Mol. Sci. 2011, 12                       
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2.4. Histopathology 
Liver  tissues,  which  were  previously  trimmed  into  2  mm  thickness,  were  fixed  with  buffered 
formaldehyde for 24 h. The fixed tissues were processed including embedded in paraffin, sectioned 
and rehydrated. The histological examination by above conventional methods was evaluated the index 
of CCl4-induced necrosis by assessing the morphological changes in the liver sections stained with 
hematoxylin and eosin (H&E). 
2.5. Biochemistry Analysis 
ALT, AST, ALP activities, TP, Alb and G, TNF-α concentration were determined with Elisa Kits. 
Hydroxyproline has been used as an indicator to determine hepatic collagen amount. The tissue 
samples (50–60 mg) were hydrolyzed in 6 M HCl at 110 °C for 24 h. After filtration, samples were 
extracted and analyzed according to the procedure of Bergman and Loxley [15]. 
Reduced glutathione was determined according to Beutler’s method [16] using Ellman’s reagent. 
The procedure is based on the reduction of Ellman’s reagent by SH groups to form 5,5′-dithiobis  
(2-nitrobenzoic acid) with an intense yellow color, measured spectrophotometrically at 412 nm using a 
Shimadzu Spectrophotometer. Results were expressed as nmol GSH/mg protein. 
Lipid peroxidation (LPO) levels in liver homogenates were estimated by Ledwozyw’s method [17]. 
In brief, the adduct formed, following boiled tissue homogenate with thiobarbituric acid, is extracted 
with n-butanol. The difference in optical density at 532 nm is measured in terms of the liver MDA 
content, also of thiobarbituric acid reactive substances (TBARS), which is undertaken as an index of 
lipid peroxidation. Results were expressed as nmol MDA/mg protein. 
SOD was assayed by following the method of Misra and Frisovich [18]. Required amount (100 μL) 
of homogenate was added to tubes containing 0.5 mL of carbonate buffer and 0.5 of EDTA solution. 
The final volume was made up to 2.5 mL. The reaction was initiated by the addition of 0.5 mL of 
epinephrine  and  increase  in  absorbance  at  480  nm  was  measured  in  a  Systronics  119  UV 
spectrophotometer.  One  hundred  percent  auto  oxidation  of  epinephrine  to  adrenochrome  was 
performed  in a control tube without the enzyme. The enzyme unit of activity was defined, as the 
enzyme required for 50% inhibition of epinephrine autooxidation.  
CAT activity was measured by the method of Aebi [19]. A 0.1 mL of supernatant was added to 
cuvette containing 1.9 mL of 50 mM phosphate buffer (pH 7.0). Reaction was started by addition of 
1.0  mL  of  freshly  prepared  30  mM  H2O2.  The  rate  of  decomposition  of  H2O2  was  measured 
spectrophotometrically at 240 nm. Activity of catalase was expressed as U/mg of protein. 
Activity of GSH-Px was determined according to the method of Lawrence and Burk [20]. The assay 
mixture consisted of 2.0  mL of 75 mM phosphate buffer (pH 7.0), 50 μL of 60  mM glutathione,  
0.1 mL of 30 units/mL glutathione reductase, 0.1 mL of 15 mM EDTA, 0.1 mL of 3 mM NADPH and 
the appropriate amount of tissue supernatant to a final volume of 3.0 mL. The reaction was started by 
the addition of 0.1 mL of 7.5 mM H2O2. The rate of change of absorbance during the conversion of 
NADPH to NADP
+ was recorded spectrophotometrically at 340 nm for 3 min. GSH-Px activity for 
tissues was expressed as μmoles of NADPH oxidized to NADP
+ min
−1 mg
−1 protein. Int. J. Mol. Sci. 2011, 12                       
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GR was assayed using reagent from Randox Laboratories; the assay was adapted from the method 
of Goldberg and Spooner [21]. GR catalyzes the reduction of oxidized glutathione in the presence of 
NADPH, which is oxidized to NADP
+. The decrease in absorbance is measured at 340 nm. One unit of 
activity is equal to the micromole of NADPH oxidized per minute per milligram of protein. 
GST activity: Total GST activity was determined as described by Habig and Jakoby [22]. Briefly, 
the enzyme activity was assayed spectrophotometrically at 340 nm in a 4 mL cuvette containing 0.1 M 
PBS  (pH  6.5),  30  mM  glutathione,  30  mM  1-chloro-2,6-dinitrobenzene  and  tissue  homogenate. 
Enzyme activity was expressed as nanomole per minute per milligram protein (nmol/min/mg protein). 
2.6. Statistical Analysis 
Statistical analysis involved used of the Statistical Analysis System software package. Analysis of 
variance  was  performed  by  ANOVA  procedures.  Significant  differences  between  means  were 
determined by Duncan’s multiple range tests at a level of P < 0.05. 
3. Results 
Toxicity  test  showed that  15  days  of  LE  treatment  did  not  significantly  affect  rats’  final  body 
weight. There was no significant difference  in average  body weight gain and  food utilization rate 
between groups (Table 1). None of experimental rats displayed toxic symptom and died. All rats had  
normal faeces. 
Table 1. Effect of licorice aqueous extract (LE) treatment on experimental rats’ average 
body weight gain and food utilization rate (n = 10). 
Group 
Initial body 
weight (g) 
Final body 
weight (g) 
Average body 
weight gain (g) 
Food utilization 
rate (%) 
0 (mg/kg b.w./day)  236.6 ± 29.9  287.5 ± 30.1  49.83 ± 5.07  34.75 ± 3.72 
50 (mg/kg b.w./day)  241.7 ± 35.3  281.9 ± 28.9  49.35 ± 5.32  33.98 ± 2.17 
100 (mg/kg b.w./day)  238.8 ± 27.4  289.6 ± 30.6  50.02 ± 4.78  35.03 ± 3.08 
150 (mg/kg b.w./day)  239.5 ± 26.2  289.2 ± 32.8  49.17 ± 5.19  33.47 ± 2.96 
200 (mg/kg b.w./day)  240.5 ± 31.1  288.1 ± 30.7  50.07 ± 4.53  34.14 ± 3.14 
250 (mg/kg b.w./day)  237.2 ± 28.3  289.1 ± 32.1  50.22 ± 4.62  35.38 ± 2.26 
300 (mg/kg b.w./day)  235.7 ± 26.7  287.4 ± 29.4  49.43 ± 4.73  35.73 ± 2.51 
Increased  fatty  degeneration,  cytoplasmic  vacuolization  and  necrosis  provided  histopathological 
evidence of tissue injury in the CCl4-treated group (Figure 1). However, these histopathologic indexes 
were significantly improved by LE and bifendate administration. CCl4 also increased the activities of 
serum  ALT,  ALT,  ALP,  and  decreased  the  levels  of  serum  TP,  Alb  and  G  in  CCl4-treated  rats 
compared to the normal control group (p < 0.01) (Table 2). Rats pre-treated with LE and bifendate 
showed a marked and significant reduction of serum ALT, ALT, ALP activities and increase of TP, 
Alb and G levels compared to the CCl4 group (p < 0.01) (Figure 1). Int. J. Mol. Sci. 2011, 12                       
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Figure  1. Histological Analysis of the Livers after CCl4 Administration. Typical images 
were chosen from the  different experimental groups (original  magnification 400×). (A) Control 
group; (B) vehicle-treated CCl4 group; (C) CCl4 and LE (150 mg/kg)-treated group; (D) CCl4 and 
LE (300 mg/kg)-treated group And (E) CCl4 and bifendate (100 mg/kg)-treated group. 
   
(A)  (B) 
   
(C)  (D) 
 
(E) 
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Table  2.  Effect  of  LE  on  serum  aspartate  aminotransferase  (AST),  alanine 
aminotransferase (ALT), alkaline phosphatase (ALP), total protein (TP), albumin (Alb) and 
globulin (G) levels in different groups. 
Group  AST (U/L)  ALT (U/L)  ALP (U/L)  TP (mg/L)  Alb (mg/L)  G (mg/L) 
NC  171.82 ± 13.54  22.13 ± 1.75  123.85 ± 11.08  71.54 ± 4.07  39.61 ± 2.08  31.22 ± 2.02 
MC (CCl4)  401.45 ± 32.07 
b  241.62 ± 2.03
 b  401.52 ± 32.98 
b  51.26 ± 3.62 
b  30.11 ± 1.65 
b  19.84 ± 1.54 
b 
CCl4 + LE (100 
mg/kg b.w.) 
289.32 ± 20.19 
d  92.57 ± 7.33 
d  299.64 ± 29.83 
d  60.05 ± 6.83 
d  33.07 ± 2.39 
c  23.18 ± 1.42 
c 
CCl4 + LE (150 
mg/kg b.w.) 
297.14 ± 22.14 
d  98.41 ± 6.05 
d  316.73 ± 27.05 
d  64.03 ± 4.42 
d  34.15 ± 2.64 
d  25.13 ± 1.66 
d 
CCl4 + LE (300 
mg/kg b.w.) 
193.17 ± 14.71 
d  41.09 ± 2.64 
d  198.37 ± 12.56 
d  69.32 ± 4.91 
d  38.53 ± 3.15 
d  29.94 ± 2.06 
d 
CCl4 + 
bifendate 
253.05 ± 19.06 
d  52.61 ± 3.35 
d  194.02 ± 10.47 
d  66.38 ± 7.03
 d  36.64 ± 1.96 
d  30.17 ± 2.36 
d 
b P < 0.01, compared with NC group; 
c P < 0.01; 
d P < 0.01, compared with CCl4-treated group. NC: normal 
control, MC: model control.  
Table 3 showed livers indices in different groups of rats. In the CCl4 (model) group, the livers index 
was 1.5-fold higher than in the normal control group (p < 0.01). Treatment with the LE (100, 150,  
300 mg/kg b.w.) reduced livers  indices to 87%, 81% and 72%, respectively (p < 0.05, p < 0.01).  
In addition, treatment with the bifendate (100 mg/kg b.w.) reduced livers indices to 70% (p < 0.01). 
Table 3. Effect of LE on liver index in different groups. 
Group  Liver index 
NC  3.41 ± 0.28 
MC (CCl4)  4.95 ± 0.22 
b 
CCl4 + LE (100 mg/kg b.w.)  4.34 ± 0.38 
c 
CCl4 + LE (150 mg/kg b.w.)  4.03 ± 0.42 
c 
CCl4 + LE (300 mg/kg b.w.)  3.56 ± 0.31 
d 
CCl4 + bifendate  3.48 ± 0.29 
d 
b  P  <  0.01,  compared  with  NC  group; 
c  P  <  0.05; 
d  P  <  0.01,  compared  with  CCl4-treated  group;  
NC: normal control. 
Table 4 showed the liver hydroxyproline levels of rats in each group. There is a significant increase 
(p < 0.01) in the liver hydroxyproline levels of CCl4-induced rats (model group) when compared with 
the normal control group. Pre-treatment of LE (100, 150, 300 mg/kg b.w.) for 15 consecutive days 
dose-dependently significantly decrease (p < 0.01) the liver hydroxyproline levels in CCl4 + LE groups 
when compared with CCl4-treated group. In addition, pre-treatment with the bifendate (100 mg/kg b.w.) 
significantly  reduced  the  liver  hydroxyproline  levels  in  bifendate-treated  (CCl4  +  bifendate)  group 
when compared with CCl4-treated group. Int. J. Mol. Sci. 2011, 12                       
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Table 4. Effect of LE on liver hydroxyproline levels in different groups. 
Group  Hyp (μg·g
−1) 
NC  99.32 ± 7.05 
MC (CCl4)  413.17 ± 33.76 
b 
CCl4 + LE (100 mg/kg b.w.)  342.32 ± 20.17 
d 
CCl4 + LE (150 mg/kg b.w.)  306.15 ± 26.08 
d 
CCl4 + LE (300 mg/kg b.w.)  174.63 ± 13.64 
d 
CCl4 + bifendate  149.27 ± 11.07 
d 
b P < 0.01, compared with NC group; 
d P < 0.01, compared with CCl4-treated group; NC: normal control. 
To evaluate the protective effect of LE on the liver oxidative damage in rats induced by CCl4, we 
determined  the  primary  antioxidant  enzymes  in  liver.  CCl4 significantly  (P  <  0.01)  increased  the 
concentrations of liver malondialdehyde (MDA) in CCl4-treated group (Table 5), which was product of 
lipid peroxidation, compared to that in normal control group. And the concentrations of liver MDA 
were dose-dependently reduced by the pre-administration of LE. As shown in Table 5, CCl4 markedly 
(P < 0.01) decreased the content of liver GSH which was reversed by LE in a dose-dependent manner. 
In addition, the content of GSH in the LE (100, 150, 300 mg/kg b.w.) treating (CCl4 + LE) groups was 
significantly (P < 0.05, P < 0.01) higher than that of normal control group.  
Table 5. Effect of LE on liver malondialdehyde (MDA) and glutathione (GSH) levels in 
different groups. 
Group  MDA (nmol/mg Prot)  GSH (mg/g Prot) 
NC  4.32 ± 2.13  154.29 ± 13.29 
MC (CCl4)  8.54 ± 4.83 
b  88.16 ± 6.72 
b 
CCl4 + LE (100 mg/kg b.w.)  7.39 ± 4.51 
c  104.32 ± 10.63 
d 
CCl4 + LE (150 mg/kg b.w.)  6.01 ± 4.21 
d  127.39 ± 11.05 
d 
CCl4 + LE (300 mg/kg b.w.)  4.17 ± 3.09 
d  150.73 ± 13.29 
d 
CCl4 + bifendate  5.73 ± 3.71 
d  144.37 ± 11.73 
d 
b  P  <  0.01,  compared  with  NC  group; 
c  P  <  0.05, 
d  P  <  0.01,  compared  with  CCl4-treated  group;  
NC: normal control. 
As shown in Table 6, a significantly (P < 0.01) increased activities of liver antioxidant enzymes 
were observed in the CCl4-treated rats compared with the normal control group. Pre-feeding the LE at 
either 100, 150 or 300 mg/kg b.w. significantly (P < 0.05, P < 0.01) enhanced the liver antioxidant 
enzymes activities (SOD, CAT, GSH-Px, GR, GST) in licorice extract-treated (CCl4 + LE) rats in a 
dose-dependent  manner.  Likewise,  pre-treatment  of  the  bifendate  (100  mg/kg  b.w.)  significantly  
(P < 0.01) elevated liver GSH level, SOD, CAT, GSH-Px, GST and GR activities, and decreased liver 
MDA level. Int. J. Mol. Sci. 2011, 12                       
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Table 6. Effect of LE on liver antioxidant enzymes activities in different groups. 
Group 
SOD  
(U/mg prot) 
CAT  
(U/mg prot) 
GSH-Px  
(U/mg prot) 
GR  
(U/g prot) 
GST  
(nmol/min/mg prot) 
NC  164.9 ± 12.67  32.65 ± 3.05  27.51 ± 1.85  31.43 ± 1.65  43.54 ± 4.21 
MC (CCl4)  83.2 ± 5.09 
b  16.93 ± 1.52 
b  10.73 ± 1.05 
b  13.16 ± 1.25 
b  21.34 ± 1.85 
b 
CCl4 + LE (100 
mg/kg b.w.) 
103.9 ± 8.01 
d  20.11 ± 1.67 
c  15.75 ± 1.93 
c  21.85 ± 1.21 
d  31.54 ± 2.86 
d 
CCl4 + LE (150 
mg/kg b.w.) 
114.5 ± 8.23 
d  22.07 ± 1.88 
d  19.32 ± 1.43 
d  22.43 ± 1.07 
d  34.21 ± 2.53 
d 
CCl4 + LE (300 
mg/kg b.w.) 
159.2 ± 11.72 
d  30.57 ± 2.53 
d  26.19 ± 1.97 
d  30.41 ± 2.63 
d  41.83 ± 3.92 
d 
CCl4 + bifendate  142.1 ± 10.61 
d  27.58 ± 2.22 
d  24.62 ± 2.31 
d  29.42 ± 1.84 
d  36.1 ± 4.17 
d 
b  P  <  0.01,  compared  with  NC  group; 
c  P  <  0.05; 
d  P  <  0.01,  compared  with  CCl4-treated  group;  
NC: normal control. 
Table 7 showed serum TNF-α levels in different groups of rats. In the CCl4 (model) group, the 
serum TNF-α levels were 5-fold higher than in the normal control group (p < 0.01). Treatment with the 
LE (100, 150, 300 mg/kg b.w.) reduced serum  TNF-α  levels to 83%,  71% and 49%, respectively  
(p < 0.01). In addition, pre-treatment with the bifendate (100 mg/kg b.w.) reduced serum TNF-α levels 
to 50% (p < 0.01). 
Table 7. Effect of LE on serum TNF-α levels in different groups. 
Group  TNF-α (pg/mL) 
NC  202.15 ± 17.84 
MC (CCl4)  993.14 ± 85.13 
b 
CCl4 + LE (100 mg/kg b.w.)  831.66 ± 75.42 
d 
CCl4 + LE (150 mg/kg b.w.)  703.12 ± 65.09 
d 
CCl4 + LE (300 mg/kg b.w.)  483.19 ± 37.24 
d 
CCl4 + bifendate  503.91 ± 46.18 
d 
b P < 0.01, compared with NC group; 
d P < 0.01, compared with CCl4-treated group; NC: normal control. 
4. Discussion 
Clinical benefits of licorice have been reported. Licorice extracts have been used in the clinical 
treatment of numerous illnesses (gastric and duodenal ulcers, bronchial asthma, infectious hepatitis, 
malaria,  diabetes  insipidus,  contact  dermatitis,  etc.)  with  considerable  success  in  China.  The  
anti-inflammatory, mucoprotective and anti-ulcer activities of licorice make it an attractive treatment 
for peptic ulcer. Licorice may lower testosterone levels in women. Licorice root is hepatoprotective, 
antihepatotoxic, and has been used successfully in clinical trials to treat viral hepatitis [23,24].  
The liver is a vital organ present in vertebrates and some other animals. It has a wide range of 
functions, including detoxification, protein synthesis, and production of biochemicals necessary for 
digestion [25,26]. A large number of plants and formulations have been claimed to have hepatoprotective 
activity.  In  China,  many  plants  medicines  possessed  hepatoprotective  activity.  They  included 
Astragalus  mongholicus,  Salvia  miltiorrhiza,  Radix  paeoniae  alba,  Angelica  sinensis,  Ligusticum Int. J. Mol. Sci. 2011, 12                       
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wallichii,  Ganodorma  lucidum  and  so on  [14]. Compared  with  other  herbs,  because  of  wonderful 
pharmacological function, licorice was most widely, single use or in formulations, applied in therapy 
of many diseases, especially liver diseases in china. Previous studies showed that licorice extract could 
significantly reduce the elevated levels of LDH, GOT, GPT and MDA and increased the reduced levels 
of  SOD  and  GSH-Px  by  CCl4  in  carp  [27].  Some  formulation,  like  licorice  Radix  paeoniae  alba 
decoction, Glycyrrhiza, Salvia Chinensis Benth Zishen decoction, could effectively protect rats against 
D-galactose-induced and CCl4-induced live injury. 
Carbon  tetrachloride  (CCl4)  has  been  widely  used  in  animal  models  to  investigate  chemical  
toxin-induced  liver  damage.  The  most  remarkable  pathological  characteristics  of  CCl4-induced 
hepatotoxicity  are  fatty  liver,  cirrhosis  and  necrosis,  which  have  been  thought  to  result  from  the 
formation of reactive intermediates such as trichloromethyl free radicals (CCl3
+) metabolized by the 
mixed function cytochrome p450 in the endoplasmic reticulum [28]. Usually, the extent of hepatic 
damage is assessed by the increased level of cytoplasmic enzymes (ALT, AST and ALP), thus leads to 
leakage of  large quantities of enzymes  into the blood circulation.  This was associated by  massive 
centrilobular necrosis, ballooning degeneration and cellular infiltration of the liver [29]. 
In this study, CCl4 treatments could modify liver function, since the activities of AST, ALP and 
ALT were significantly higher, and levels of TP, Alb and G were significantly lower than those of 
normal values as compared with the control group. In addition, liver index in the CCl4-treated rats 
were  significantly  higher  than  those  of  normal  values  as  compared  with  the  control  group.  This 
indicated that the model had been successfully built. It was more important to confirm whether there is 
any difference between the treatment with or without licorice extract under the damage of CCl4. The 
results showed that pre-treatment of rats with licorice extract effectively protected the animals against 
CCl4-induced hepatic destruction, as evidenced by decreased serum AST, ALT, and ALP activities and 
increased TP, Alb and G levels. In the histological examination, pre-treatment with licorice extract or 
bifendate suppressed the acute hepatic damage and was consistent with improvement of the serum 
biological parameters for hepatotoxicity. 
CCl4 is a well-known hepatotoxic agent. The basis of its hepatotoxicity lies in its biotransformation 
by  the  cytochrome  P450  system  to  two  free  radicals.  The  first  metabolite,  a  trichloromethyl  free 
radical,  forms covalent adducts with  lipids and proteins;  it can  interact with O2 to form a second 
metabolite, a trichloromethylperoxy free radical, or can remove hydrogen atoms to form chloroform [30]. 
Since free radicals play such an important role in CCl4-induced hepatotoxicity, it seems logical that 
compounds that neutralize such radicals may have an hepatoprotective effect. Indeed, various natural 
products have been reported to protect against CCl4-induced hepatotoxicity [31]. The medicinal herb 
Artemisia campestris has been found to scavenge free radicals and therein to exert a hepatoprotective 
effect  against  CCl4-induced  liver  injury  [32].  Similarly,  ginsenosides  are  reported to  contribute  to 
protection against CCl4-induced hepatotoxicity in rats, ostensibly by their antioxidant properties [33]. 
Antioxidant enzymes (SOD, GPx, GR, GST and catalase) represent one protection against oxidative 
tissue-damage [34]. SOD converted O2 into H2O2. GPx and catalase metabolize H2O2 to non-toxic 
products. The GSH antioxidant system plays a fundamental role in cellular defense against reactive 
free radicals and other oxidant species. This system consists of GSH and an array of  functionally 
related enzymes, of which GR is responsible for the regeneration of GSH, whereas GPx and GST work 
together with GSH in the decomposition of hydrogen peroxide other organic hydroperoxides [35]. The Int. J. Mol. Sci. 2011, 12                       
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results obtained indicate increased MDA levels in the liver in response to CCl4 treatment, implying 
increased oxidative damage to the liver. CCl4 also caused an increased in GPx, SOD, GR, GST and 
catalase activities in the liver over those of the control group. Under oxidative stress, some endogenous 
protective factors such as GPx and catalase are activated in the defense against oxidative injury [36]. 
For example, organophosphate pesticides such as dimethoate and malathion were shown to increase 
oxidative stress and consequently increase SOD and catalase activities in erythrocytes of rats [37]. This 
increase in enzyme activities was probably a response towards increased ROS generation in pesticides 
toxicity. In this work, licorice extract pre-treatments returned the increased MDA and decreased GSH, 
antioxidant enzymes levels back to their control levels, implying that licorice extract may prevent the 
peroxidation of lipids by CCl4. 
Because antioxidants are reported to exert anti-inflammatory activity [38], we also evaluated the  
in  vivo  anti-inflammatory  activity  of  licorice  extract  by  measuring  release  of  TNF-α,  a  
pro-inflammatory cytokine that becomes elevated in acute and chronic diseases. Our work showed that 
pre-treatment of licorice extract could decrease serum TNF-α levels in CCl4-treated rats. TNF-α was 
found to mediate the induction of hepatotoxicity and fibrogenesis in the bile duct ligation model [39]. 
Phytochemicals  have  been  shown  to  inhibit  inflammation  by  blocking  inflammatory  pathways 
downstream of cytokine release [40], and also by reducing macrophage production of proinflammatory 
factors [41]. 
Bernardi et al. [42] evaluated the effects of graded doses of pure licorice root extract in order to 
identify the dosages leading to mineralocorticoid-like side effects. Two subjects from the 814 mg/day 
group were forced to withdraw from the study due to headaches, hypertension, hypokalemia and/or 
edema. Sigurjonsdottir et al. [43] monitored the effects of moderate consumption of licorice on blood 
pressure, plasma and urinary electrolytes, and urinary cortisol. He concluded that moderate licorice 
consumption can induce hypertensive effects, but the extent of these effects varies greatly between 
individuals. Moreover, licorice in combination with other components (Coptis chinensis, Amur corktree 
bark, Corydalis tuber, Ephedra, etc.) in prescription can promote effective components of medicines to 
precipitate, and decrease their biological availability in body. Heavy licorice (glycyrrhizin) consumption 
has  been  associated  with  shorter  gestation  [44].  Heavy  glycyrrhizin  exposure  was  associated  with 
preterm delivery and may be a novel marker of this condition. Therefore, high dose of licorice should 
be cautiously used in clinic.  
The main components of licorice root are the triterpene, saponins, glycyrrhizin/glyccyrrhizic acid 
and glycyrrhetic acid. Glycyrrhizic acid (GA) exhibits a number of pharmacological effects including 
anti-inflammatory  and  is  used  in  hepatoprotective  formulations.  Pre-treatment  with  GA  has  been 
reported to show protective action against carbon tetrachloride (CCl4)-induced liver injury in rats [45]. 
Tsuruoka et al. [46] reported that glycyrrhizin (10.5 mg/kg) suppressed the increases in AST and ALT, 
inhibited iNOS mRNA expression and protein, cell infiltration and the degeneration of hepatocytes in 
the  liver  of  concanavalin  A  (Con  A)-treated  mice.  Lee  et  al.  reported that  glycyrrhizin  alleviates  
CCl4-induced liver injury by diminishing free radical toxic properties and inducing heme oxygenase-1 
and downregulating proinflammatory mediators [47]. Lin et al. reported that a three-day pretreatment 
with either glycyrrhizin or glycyrrhetinic acid exhibited protective effect on retrorsine-induced liver 
damage in rats [48]. Wan et al. reported that compared with glycyrrhizin or matrine alone, combined 
use of glycyrrhizin and matrine can reduce the mortality of acetaminophen overdosed mice, attenuate Int. J. Mol. Sci. 2011, 12                       
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the development of acetaminophen-induced hepatotoxicity in mice, and reduce the number and area of 
γ-GT  positive  foci,  thus  protecting  liver  function  and  preventing  hepatocellular  carcinoma  from 
occurring [49]. In addition, it has a protective effect on immunosuppression and a strong non-specific 
anti-inflammatory effect and an effect of reducing the incidence of sodium and water retention, without 
causing significant adverse effects. Saponins, triterpenes, sterols and bitter principles were identified in 
the  n-hexane  extract  of  Lygodium  flexuosum.  The  n-hexane  extract  of  Lygodium  flexuosum  was 
reported as a hepatoprotective  agent against carbon tetrachloride-induced  hepatotoxicity [50]. This 
indicated  that  saponins,  triterpenes  might  possess  hepatoprotective  activities.  We  supposed  that  
the  components  (triterpene,  saponins,  glycyrrhizic  acid)  in  single  or  in  combination  with  other 
components present in the licorice extract might be responsible for the reduction of hepatotoxicity in 
treatment groups. 
Based on the experimental results reported here, we hypothesize that licorice extract may play an 
important role in medicine by scavenging free radicals, stimulating activities of antioxidant enzymes, 
and  arresting  production  of  inflammatory  cytokine,  subsequently  protecting  the  liver  against  
CCl4-induced damage. We supposed that the components (triterpene, saponins, glyccyrrhizic acid) in 
single or in combination with other components present in the licorice extract might be responsible for 
the reduction of hepatotoxicity in treatment groups. 
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